Biogen Inc.

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spina…

Drug Manufacturers - General

US, Cambridge [HQ]

Overview
Fin. Reports
Financials
Leadership & Strategy
Government, Law & Regulation
Employees
More

News

Theses · Events · Sentiments

Articles

24-11-14

Citi Starts Neutral Coverage on Biogen Stock

Citi analysts initiated coverage on Biogen (NASDAQ:BIIB) with a Neutral rating and a price …

Sentiments

24-10-30 32.80%

Biogen reported third-quarter revenue and adjusted earnings that topped expectations. The company also raised its full-year profit guidance.